Covance to Present at UBS Global Life Sciences Conference
September 18 2009 - 11:24AM
PR Newswire (US)
PRINCETON, N.J., Sept. 18 /PRNewswire-FirstCall/ -- Covance Inc.
(NYSE: CVD) today announced that it will present at the UBS Global
Life Sciences Conference on Monday, September 21, 2009 at 10:00
a.m. (ET). Investors may access a live webcast of the presentation
at http://www.covance.com/. In order to register and download any
necessary software, please log on 10 minutes early. Covance, with
headquarters in Princeton, New Jersey, is one of the world's
largest and most comprehensive drug development services companies
with annual revenues greater than $1.7 billion, global operations
in more than 25 countries, and more than 10,000 employees
worldwide. Information on Covance's products and services, recent
press releases, and SEC filings can be obtained through its website
at http://www.covance.com/. DATASOURCE: Covance Inc. CONTACT:
Investor Relations, +1-609-452-4807 Web Site:
http://www.covance.com/
Copyright